{"name":"Dance Biopharm Inc.","slug":"dance-biopharm-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNMmNBR1FYUk9mTWJEY1hlWGp3VGctQWxndHBCRWdTYUVlTVM0b2Q1N0REU2RKZlJhQWFDTmV5YzBCUk12enVHcU9FQTA4NXpaOEcwclpQZ0dQLUpaU0JrTTdJZ3JKMjNhaG9MT3I0cHFxbDE5dkZ4QWZvQXphTFpzZzdwWnUteWV4Mk9waFVFRWhyWjRaX2V4bUFLeThiT3FsTHpLX0NmUlY0MkFn?oc=5","date":"2024-08-30","type":"pipeline","source":"The Business Journals","summary":"Durham firm raised $80 million. Now the company is gone. - The Business Journals","headline":"Durham firm raised $80 million. Now the company is gone.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AJBVV95cUxOcWdtWlF4SU1sUzlOOXlKU2g1Yjh6YlYzS0ZYSlFuZHhubDhYd19Cc0V2NUFEcXlSeURLbkVzSHBSaWFEWFRKVnJKbFpkby1pa3VGR3k3UHlnOF9Gd1NlTk55WmlsQ0FMLTU4ZWNkUmF0azVRVGJYTnlaQ2g4bFFVeVI3djFZWXBNZ1BMT0MwTlVfdUZMeEZ6SW1pak1udWFHUldYLU9pemh2b0YxSGttRnBoZnd6SU9TOVl1cjAwcHRSaDRxSEQzaVBmVnFNdDFQMzhFRVNrOU9ONEdLTHB6ZDE3aGtqNTNRdF8tYXJYNWQ4cnRCVTR2cUtfa0IxVDZWa3FRa0h0UFUxMVJ5bFF0aVYybjNzb29nTWJISVEyU1g3aVhzSjRQNlV1cjJkV2FKRmd3TVVmR24wWjRrWUxOLXh6X1NqUmVMUUNIZFFxdEJTZ1ZoZmN6TFRVaWN3U0huc2tNdQ?oc=5","date":"2024-03-13","type":"deal","source":"Business Wire","summary":"Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and Milestone Payments for Deals Signed Since 2020 - ResearchAndMarkets.com - Busin","headline":"Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNYUFIZHlSTXcwNlFla3NySHM1NDZ6MU1tVlE0RlVxQUktMHVpX0gxZVNLNzNkTFk3b2hlZ2k5dGN5WldHbUVzbS12VGVPSUlZN0w2RzZkYmdhUmhETEQwcEpUTjV3bm5oZUZSNVRESzdtb0ZRbnhQX3JORk0xTjFBUEFFX3h0Sl9pUWRPenZXQjRfQ3BxUlNKdmstMXdjSXNOMXFwNEZaYnlfdVJzOUtZa0ZGM01xVElsNUU3eHFnWGdpSVZoYnZCQ2I2MTRMU25HRHgyR1IxTWhsRndPdTlidXlnMm1WSG5hQnFR?oc=5","date":"2023-03-01","type":"pipeline","source":"Proactive Investors","summary":"Therma Bright appoints inhaled drug pioneer Dr John Patton as chairman of InStatin - Proactive Investors","headline":"Therma Bright appoints inhaled drug pioneer Dr John Patton as chairman of InStatin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOamdMY3Z2bjVsMXo5bUZIQ3JRanAzUlhQU3JaVVpJM3BIYThsSWpZYVFpejdKWGhTTTlBcVB4Rmx3ZFBodHRMWWdJdFlfUzZGWVFDZTRVR0lfWndjNjRjVnp1N0xVd0t5RXVRNEg2ckVFYlRyNElLOWs1X18tV0hfM2VnRTM0aFJQMy1ES1VtR043ZHRES1FBRnBUTGQwVHJrSVl5dWZxYUYySkFHZF9jM3JB?oc=5","date":"2021-12-07","type":"deal","source":"Drug Delivery Business","summary":"Inhaled drug delivery tech company Aerami to go public through SPAC merger - Drug Delivery Business","headline":"Inhaled drug delivery tech company Aerami to go public through SPAC merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOdE1pQndhbFhsR25QbTZub3g1YllMR2hEeklFMGlKdDV1cWF0MzRVV0E3UFRPUGJhZWtpSTA4NFY3cFo1R1FraWVoWm1PdW10SGNSenNLRTVzWHdrTkZJOTlrSHdCclhOR1pmQk13eWRNQUZTVGd6Sy1nT05GYUJCOGxXQm1vLVB1My1mNnVkM0lBV05YN2x0VmwwSXFFS0lQc3lZdWlpMFlBZk1faERzNGpxQWZVdXhlM29WdC1n?oc=5","date":"2021-01-06","type":"pipeline","source":"PR Newswire","summary":"Viking Therapeutics Announces Senior Management Team Appointments - PR Newswire","headline":"Viking Therapeutics Announces Senior Management Team Appointments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQWUtfckZMWWFiQVZWc2N0ei1NRHpybXhwV19IU2xJd05MalB5WVhCRDJPVnNPYzhXQ2dLRWM2SERaeTNva0F1R1hNWXh1anhiTWxEZmZQMC1BdEJpZ3JxR3JqTllreTRqMHhFMldQZU0tOEdwckxzNzhQNDdHWXZZY2g1SXFCLUhVVENtSnN1dkU2UkxSUWdZajZmd2RFUEdScUlyTG53?oc=5","date":"2020-07-16","type":"trial","source":"Clinical Leader","summary":"A Quick Transition From Research Firm To Clinical-Phase Biotech - Clinical Leader","headline":"A Quick Transition From Research Firm To Clinical-Phase Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQbjJLV0VQemtGeGFBaWZCOGZtamFfYVU0M1FEUDlndlVidE9kNnBQZ3QyTkRmeGNlRjNSTnBFczRUZmVwcDdDUGZzbzRFR2xER1g0U29xNlgtaVNodHR2OWw1d2hYN0p2ZFR4c1lQSHB0TDZNcmZza1hQaFI3N2FZVFZuSVc0dHM4aXZjMWlxRzhsejBkNzROZWt2YlE3cHp5eG1XWWl5UGp5Z1BVdEhzSA?oc=5","date":"2019-09-27","type":"pipeline","source":"The Business Journals","summary":"Drug company's Bay Area exodus: All about a new CEO, the right talent — and getting out of founder's living room - The Business Journals","headline":"Drug company's Bay Area exodus: All about a new CEO, the right talent — and getting out of founder's living room","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPamtWQlRyb0xMUXpaN0hJUF8wN3cxdVJNYlVQSGRJUGtmOHJuS2ZOaHQwSWxaT0pKWnQySHZ5ZlRlR1h0Vm9KVHBuS3FKMDZLWE1rTFVRLW94eFMyMXNzbDhKM0Z0emdoVE40STE1bDBndklaakxwZDRFMlBrOUNlM3JLNmNqYkhCWjMtanFpY2U0Qm5qQ29BMlgySHhtVzBrSC1rWi1aNFVGWS1L?oc=5","date":"2019-09-17","type":"pipeline","source":"Crain's New York","summary":"Weill Cornell to cut students' medical debt, but will this meet patients' needs? - Crain's New York","headline":"Weill Cornell to cut students' medical debt, but will this meet patients' needs? - Crain's New York","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQM2dvZTNNZUdkWFFVeDNvOFcyeERzODZNdmFyS1RYbkR5YjIzOUlUc2s2VVo1dWtrRnlldWtrbG01WEpxNHVaenU2aVZOSFl5VFd4SkhiUHd0c1g2LTdPNjFRNWN6emc0bndrMnVyT2Z6dlpGSVlOaVVEVnJRVDU0YjlBcy1BUWFtUkVGRlo0VURaZU1MNlQ4RDFHX0FtR2Jh0gGoAUFVX3lxTE9FMHJiT2JycXJPRDd1MUdaTDJXN2FZTDFxRTE1ajgyZDRhU1RNRE5qcTFRcHhucWdaNDJsWndPZjRMcEJfWGVsYWZ2bVNWRXNqbDVxYXI5aUYydXd1MXVzV0ZMM05rdVI2XzVNTkVQSklwXzFVUm1TbzdhVXFnU2hxU0lLQlVzNEk5d013d1E0bVVNcW5JczV0ZUtWdnp3ODIzQ1RGUG16SQ?oc=5","date":"2015-09-25","type":"pipeline","source":"warriortradingnews.com","summary":"MannKind Corporation (MNKD) Stock | Mannkind at a Crossroads - warriortradingnews.com","headline":"MannKind Corporation (MNKD) Stock | Mannkind at a Crossroads","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUlkyNTVkOEdadlFIUjQ1bzFCcDQ4OFRBX0NMNUJXOGdVYzZsNC1UTDRVM3A2Wnc3blNoSkctaUxzTW9NY1BEYXAxM3ZtMjdQYW1TZzJ0c0wtWU1hQmc0ZkUwMHlkc3BBcXhjZlhsTHlZTlZMd0k0NnZPSVNUTnBwYnJTQ2h3SmkzNEJrSHNn?oc=5","date":"2014-04-11","type":"pipeline","source":"Nanalyze","summary":"Inhaled Insulin Company Dance Biopharm Looks to IPO - Nanalyze","headline":"Inhaled Insulin Company Dance Biopharm Looks to IPO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}